References
- Jayson M IV, Keegan A, Million R, Tomlinson I. A fibrinolytic defect in chronic back pain syndromes. Lancet 1984; ii: 1186–7
- Pountain G D, Keegan A L, Jayson M IV. Impaired fibrinolytic activity in defined chronic low-back pain syndromes. Spine 1987; 12: 83–6
- Parish W E. Features of human spontaneous vasculitis reproduced experimentally in animals. Effect of antiglobulin, C-reactive protein and fibrin. Bayer Symposium VI, Experimental models of chronic inflammatory diseases. Springer-Verlag, Berlin, Heidelberg 1977; 117–51
- Astrup T, Mullertz S. Fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952; 40: 346–51
- Isacson S, Nielson I M. Defective fibrinolysis in blood and veinwalls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand 1972; 138: 313–9
- Jespersen J, Astrup T. A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis 1983; 13: 301–15
- Meade T W, Chakrabarti R, Haines A P, North W RS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979; i: 153–6
- Wu A VO, Mansfield A O. The relation between the blood and vein wall fibrinolytic activities in response to surgical trauma. Acta Haematol 1980; 63: 191–95
- Moroz L A. Increased blood fibrinolytic activity after aspirin ingestion. N Engl J Med 1977; 196: 525–9
- Levin R I, Harpel P C, Wiel D, Chang T-S, Rifkin D B. Aspirin inhibits plasminogen activator activity in vivo. J Clin Invest 1984; 74: 571–80